LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

Assertio Holdings Inc

Slēgts

0.64 3.23

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.62

Max

0.65

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.1M

-14M

Pārdošana

-5.7M

26M

EPS

-0.04

Peļņas marža

-51.121

Darbinieki

58

EBITDA

-10M

-13M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+344.44% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4.4M

63M

Iepriekšējā atvēršanas cena

-2.59

Iepriekšējā slēgšanas cena

0.64

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Assertio Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. jūn. 22:33 UTC

Iegādes, apvienošanās, pārņemšana

KKR to Acquire Australian Power Provider Zenith Energy

2025. g. 16. jūn. 21:55 UTC

Galvenie tirgus virzītāji

Geospace Technologies Shares Up on Petrobras Pact

2025. g. 16. jūn. 17:04 UTC

Galvenie tirgus virzītāji

Roku Shares Climb on Advertising Deal with Amazon

2025. g. 16. jūn. 23:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. jūn. 23:51 UTC

Tirgus saruna

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

2025. g. 16. jūn. 23:41 UTC

Tirgus saruna

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

2025. g. 16. jūn. 23:10 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

2025. g. 16. jūn. 23:02 UTC

Tirgus saruna

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

2025. g. 16. jūn. 22:32 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

2025. g. 16. jūn. 22:03 UTC

Iegādes, apvienošanās, pārņemšana

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

2025. g. 16. jūn. 22:00 UTC

Iegādes, apvienošanās, pārņemšana

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

2025. g. 16. jūn. 21:56 UTC

Peļņas

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

2025. g. 16. jūn. 21:10 UTC

Iegādes, apvienošanās, pārņemšana

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

2025. g. 16. jūn. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 16. jūn. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 16. jūn. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 16. jūn. 20:49 UTC

Tirgus saruna

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

2025. g. 16. jūn. 20:14 UTC

Iegādes, apvienošanās, pārņemšana

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

2025. g. 16. jūn. 20:13 UTC

Tirgus saruna

Natural Gas Gains on Warmer Outlook -- Market Talk

2025. g. 16. jūn. 19:58 UTC

Iegādes, apvienošanās, pārņemšana

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

2025. g. 16. jūn. 19:13 UTC

Tirgus saruna

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

2025. g. 16. jūn. 19:09 UTC

Tirgus saruna

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

2025. g. 16. jūn. 18:43 UTC

Tirgus saruna

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

2025. g. 16. jūn. 18:36 UTC

Tirgus saruna

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

2025. g. 16. jūn. 18:29 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. jūn. 18:29 UTC

Tirgus saruna

Shopify Appears More Resilient Than Feared -- Market Talk

2025. g. 16. jūn. 18:22 UTC

Tirgus saruna

Citi Forecasts Downturn in Gold Futures -- Market Talk

2025. g. 16. jūn. 16:42 UTC

Tirgus saruna

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

2025. g. 16. jūn. 16:37 UTC

Tirgus saruna

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

2025. g. 16. jūn. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Assertio Holdings Inc Prognoze

Cenas mērķis

By TipRanks

344.44% augšup

Prognoze 12 mēnešiem

Vidējais 2.8 USD  344.44%

Augstākais 3.5 USD

Zemākais 1.5 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Assertio Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

5 ratings

4

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.618 / 0.649Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.